Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aviva Katzav

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of Autoimmunity|July 22, 2014
Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine modelNancy Agmon-Levin, María-Teresa Arango, Shaye Kivity, et al.
BMC Medicine|April 6, 2013
16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupusShaye Kivity, Aviva Katzav, Maria Teresa Arango, et al.
Pathology, Research and Practice|December 24, 2023
Complete digital pathology transition: A large multi-center experienceBenzion Samueli, Natalie Aizenberg, Ruthy Shaco-Levy, et al.
Molecular Oncology|March 2, 2024
The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancerAdi Alfandari, Dotan Moskovich, Avivit Weisz, et al.
Oncogene|September 24, 2021
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Cancer Letters|November 22, 2020
DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancerDotan Moskovich, Adi Alfandari, Yael Finkelshtein, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 2, 2026
DIO3 associates with sorting nexins and endosomal trafficking networks in ovarian cancerDaniel Maman-Shinar, Shachar Vanmak, David Bern, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of Autoimmunity|July 22, 2014
Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine modelNancy Agmon-Levin, María-Teresa Arango, Shaye Kivity, et al.
BMC Medicine|April 6, 2013
16/6-idiotype expressing antibodies induce brain inflammation and cognitive impairment in mice: the mosaic of central nervous system involvement in lupusShaye Kivity, Aviva Katzav, Maria Teresa Arango, et al.
Pathology, Research and Practice|December 24, 2023
Complete digital pathology transition: A large multi-center experienceBenzion Samueli, Natalie Aizenberg, Ruthy Shaco-Levy, et al.
Molecular Oncology|March 2, 2024
The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancerAdi Alfandari, Dotan Moskovich, Avivit Weisz, et al.
Oncogene|September 24, 2021
Targeting the DIO3 enzyme using first-in-class inhibitors effectively suppresses tumor growth: a new paradigm in ovarian cancer treatmentDotan Moskovich, Yael Finkelshtein, Adi Alfandari, et al.
Cancer Letters|November 22, 2020
DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancerDotan Moskovich, Adi Alfandari, Yael Finkelshtein, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 2, 2026
DIO3 associates with sorting nexins and endosomal trafficking networks in ovarian cancerDaniel Maman-Shinar, Shachar Vanmak, David Bern, et al.
Pageof 4